The historical rank and industry rank for Beijing Beilu Pharmaceutical Co's EV-to-FCF or its related term are showing as below:
SZSE:300016'
s EV-to-FCF Range Over the Past 10 Years
Min: -9145.89 Med: 61.33 Max: 1566.64
Current: -30.32
During the past 13 years, the highest EV-to-FCF of Beijing Beilu Pharmaceutical Co was 1566.64. The lowest was -9145.89. And the median was 61.33.
SZSE:300016's EV-to-FCF is ranked worse than 100% of 536
companies
in the Drug Manufacturers industry
Industry Median: 22.75
vs SZSE:300016: -30.32
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Beijing Beilu Pharmaceutical Co's EV-to-FCF
For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Beilu Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Beilu Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beijing Beilu Pharmaceutical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Beijing Beilu Pharmaceutical Co's EV-to-FCF falls into.
Beijing Beilu Pharmaceutical Co EV-to-FCF Calculation
Beijing Beilu Pharmaceutical Co's current Enterprise Value is ¥2,263.4 Mil.
Beijing Beilu Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-75.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Beilu Pharmaceutical Co (SZSE:300016) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Beijing Beilu Pharmaceutical Co's PE Ratio for today is calculated as:
Beijing Beilu Pharmaceutical Co's share price for today is ¥4.41.
Beijing Beilu Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.152.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Beijing Beilu Pharmaceutical Co EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Beijing Beilu Pharmaceutical Co (SZSE:300016) Business Description
Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300016 has been successfully added to your 